Login

Interview with John Lai, CEO & President of PetVivo Holdings, Inc., highlighting company insights and future plans. 00:10:00

Share On Facebook Share On Twitter

John Lai is Pres/CEO/IR/Co-Founder, Petvivo Holdings Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Kenex Mines' High-Grade Copper Discoveries and Exploration Plans in Manitoba
00:10:00
Basel III: A Critical Look at Banking Reform and Risk | Insights from Wharton Experts
00:10:00
Pelion Venture Partners helps entrepreneurs and invests in early-stage B2B|Jeff Kearl,Partner,Pelion Venture Partners
00:10:00
Urs Jordi Confident in Aryzta's Future Amidst Profitability Challenges | Urs Jordi, CEO, Aryzta Inc.
00:10:00
ABN AMRO CEO Robert Shaak on Collective Responsibility for Sustainability|Robert Swaak, CEO , ABN AMRO.
00:10:00
BlackEarth Minerals: Advancing Critical Commodities through Exploration and Development
00:00:00
Alligator Bioscience restructuring as part of long-term strategy - Søren Bregenholt , CEO, Alligator Bioscience
00:10:00
Vulcan Energy Leaders Share Progress on Zero Carbon Lithium™ Phase One | Francis Wedin , CEO, Vulcan Energy Resources Ltd.
00:10:00
Future of Banking: A Conversation with Richard Quest | Piyush Gupta , CEO,  DBS Bank .
00:10:00
Empowering Financial Success: Personalized, Fee-Only Planning with David Clark.
00:10:00
Unlocking the Power of Your Stimulus Check: Step 4 of 5 Vital Financial Moves | Wakefield Hare - Financial Planner, Greater Than Financial
00:10:00
Phost's Breakthrough in Neurodegenerative Disease Treatment: CEO Michael Thern on Accelerated FDA Approval for Monipentel|Dr Michael Thurn,Managing Director & Chief Executive Officer,PharmAust Ltd.

© 2017 - Neuhu+